| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.17 | 8e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.2 | 9e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.17 | 0.0005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.18 | 0.0007 |